This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Jan;28(1):1-4.

doi: 10.1007/s002590000352.

123I-IMT SPET: introducing another research tool into clinical neuro-oncology?

P Matheja, O Schober

PMID: 11202443
DOI: 10.1007/s002590000352

Review

123I-IMT SPET: introducing another research tool into clinical neuro-oncology?

P Matheja et al. Eur J Nucl Med. 2001 Jan.

. 2001 Jan;28(1):1-4.

doi: 10.1007/s002590000352.

Authors

P Matheja, O Schober

PMID: 11202443
DOI: 10.1007/s002590000352

No abstract available

PubMed Disclaimer

Comment in

The history of 123-iodo-methyl tyrosine.
Biersack HJ. Biersack HJ. Eur J Nucl Med. 2001 Mar;28(3):396. doi: 10.1007/s002590100496. Eur J Nucl Med. 2001. PMID: 11315610 No abstract available.

Similar articles

Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Bader JB, Samnick S, Moringlane JR, Feiden W, Schaefer A, Kremp S, Kirsch CM. Bader JB, et al. Eur J Nucl Med. 1999 Feb;26(2):144-51. doi: 10.1007/s002590050370. Eur J Nucl Med. 1999. PMID: 9933348
123I-IMP SPET in the diagnosis of primary central nervous system lymphoma.
Yoshikai T, Fukahori T, Ishimaru J, Kato A, Uchino A, Tabuchi K, Kudo S. Yoshikai T, et al. Eur J Nucl Med. 2001 Jan;28(1):25-32. doi: 10.1007/s002590000408. Eur J Nucl Med. 2001. PMID: 11202448 Clinical Trial.
3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
Schmidt D, Gottwald U, Langen KJ, Weber F, Hertel A, Floeth F, Felsberg J, Reifenberger G, Coenen HH, Müller-Gärtner HW. Schmidt D, et al. Eur J Nucl Med. 2001 Jul;28(7):855-61. doi: 10.1007/s002590100553. Eur J Nucl Med. 2001. PMID: 11504082
[The role of L-3-I-123-iodine-alpha-methyltyrosine SPECT in cerebral gliomas].
Weckesser M, Schmidt D, Matheja P, Coenen HH, Langen KJ. Weckesser M, et al. Nuklearmedizin. 2000 Dec;39(8):233-40. Nuklearmedizin. 2000. PMID: 11189900 Review. German.
Iodine-123 labelled radiopharmaceuticals and single-photon emission tomography: a natural liaison.
Bourguignon MH, Pauwels EK, Loc'h C, Mazière B. Bourguignon MH, et al. Eur J Nucl Med. 1997 Mar;24(3):331-44. doi: 10.1007/BF01728774. Eur J Nucl Med. 1997. PMID: 9143474 Review.

See all similar articles

Cited by

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC. Bleeker G, et al. Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Cochrane Database Syst Rev. 2015. PMID: 26417712 Free PMC article.
The history of 123-iodo-methyl tyrosine.
Biersack HJ. Biersack HJ. Eur J Nucl Med. 2001 Mar;28(3):396. doi: 10.1007/s002590100496. Eur J Nucl Med. 2001. PMID: 11315610 No abstract available.

References

1. Eur J Nucl Med. 1999 Oct;26(10):1274-8 - PubMed
1. Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):517-26 - PubMed
1. Strahlenther Onkol. 2000 Apr;176(4):180-5 - PubMed
1. Eur J Nucl Med. 2000 May;27(5):550-8 - PubMed
1. J Nucl Med. 2000 Jul;41(7):1250-5 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer